Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-031344
Date:2021-05-06
Issuer: EMMAUS LIFE SCIENCES, INC. (EMMA)
Original Submission Date:

Reporting Person:

NIIHARA YUTAKA
21250 HAWTHORNE BLVD.
SUITE 800 TORRANCE, CA 90503

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, $0.001 PAR VALUE 2021-05-06 P 1,000 a $1.27 10,709,746 f1 direct
COMMON STOCK, $0.001 PAR VALUE 2021-05-07 P 2,000 a $1.23 10,711,746 f1 direct
COMMON STOCK, $0.001 PAR VALUE 2021-05-10 P 3,000 a $1.15 10,714,746 f1 direct
COMMON STOCK, $0.001 PAR VALUE 0 $0.00 92,794 indirect f3
COMMON STOCK, $0.001 PAR VALUE 0 $0.00 63,000 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the shares shown include shares owned jointly with soomi niihara, the reporting person's wife.
f2 the price reported is a weighted average price. these shares were purchased in multiple transactions at prices ranging from $1.14 to $1.15, inclusive. the reporting person undertakes to provide to emmaus life sciences, inc., any security holder of emmaus life sciences, inc., and the staff of the securities and exchange commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2).
f3 hope international hospice, inc, is a california corporation of which dr. niihara and his wife are the sole shareholders and directors.

Elevate your investments